Market Overview

Galmed Pharma (NASDAQ: GLMD)

3.75 -0.07 (-1.70%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/08/21Raymond JamesMaintainsOutperform17.0
11/25/20Canaccord GenuityMaintainsBuy20.0
5/22/20B. Riley FBRDowngradesNeutral8.0
5/15/20Raymond JamesMaintainsOutperform20.0
3/13/20StifelMaintainsBuy25.0
3/13/20B. Riley FBRMaintainsBuy11.0
2/04/20Craig-HallumInitiates Coverage OnBuy18.0
1/30/20Cantor FitzgeraldAssumesOverweight14.0
7/22/19Laidlaw & Co.Initiates Coverage OnBuy25.0
12/12/18B. Riley FBRInitiates Coverage OnBuy28.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter